ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2018
Worsening trends in analgesics recommended for spinal pain in primary care.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Antidepressants for low back pain and spine-related leg pain.The Cochrane database of systematic reviews · 2025Pooled it
- Efficacy, acceptability, and safety of antidepressants for low back pain: a systematic review and meta-analysis.Systematic reviews · 2021Pooled it
- Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018Pooled it
- Changes in Pregabalin Dispensing to Australians with Workers' Compensation Claims for Low Back Pain Following the Listing of Pregabalin on the Pharmaceutical Benefits Scheme.Journal of occupational rehabilitation · 2026Article
- Perioperative opioid prescribing concerns in anterior cervical surgery.Journal of spine surgery (Hong Kong) · 2026Article
- General practitioners' experiences of managing low back pain in primary care in Ireland: A qualitative phenomenological study.PloS one · 2025Article
- Article
- Analgesia for non-specific low back pain.BMJ (Clinical research ed.) · 2024Article
- Secular trends in gabapentinoid dispensing by compensated workers with low back pain: a retrospective cohort study.Occupational and environmental medicine · 2024Article
- Understanding general practitioners' prescribing choices to patients with chronic low back pain: a discrete choice experiment.International journal of clinical pharmacy · 2024Article
- General practitioners' decision-making process to prescribe pain medicines for low back pain: a qualitative study.BMJ open · 2023Article
- Using general practitioners with an extended role in spinal practice for the initial assessment of patients referred to spinal surgeons: preliminary experience and challenges.Primary health care research & development · 2023Review
- Efficacy and Safety of Medicines Targeting Neurotrophic Factors in the Management of Low Back Pain: Protocol for a Systematic Review and Meta-analysis.JMIR research protocols · 2021Article
- Analgesic medicines for adults with low back pain: protocol for a systematic review and network meta-analysis.Systematic reviews · 2020Article
- Comparison of Pregabalin Versus Placebo in Reduction of Pain due to Lumber Disc Herniation.Cureus · 2020Article
- Effects of pregabalin on spinal fusion.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLimited evidence exists on secular trends of analgesics for spinal pain. We investigated general practitioner's (GP) recommendations of analgesic medicines for spinal pain and investigated characteristics associated with their recommendation.
methodsWe accessed data on spinal pain consultations from the Bettering the Evaluation and Care of Health (BEACH) database, a nationally representative database on GP activity in Australia. Data extracted included consultation details and management provided. Medicines recommended were grouped as simple analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), opioid analgesics or neuropathic pain medicines. Multivariate logistic regression determined if patient characteristics and GP characteristics were associated with medication recommendations.
resultsWe analysed BEACH data for 9100 GPs who managed 39,303 patients with spinal pain between 2004 and 2014. Over the decade, analgesic recommendations increased. After accounting for patient and GP characteristics, there was a significant increase in the rate single-ingredient opioid analgesics [annual relative increase of 6% (RR 1.06 (95% CI 1.05-1.07), P < 0.001)] and neuropathic pain medicines [annual relative increase of 19% (RR 1.19 (95% CI 1.16-1.22), P < 0.001)] were recommended; and a significant decrease in the rate NSAIDs were recommended [annual relative decrease of 4% (RR 0.96 (95% CI 0.95-0.97), P < 0.001)]. Logistic regression identified several patient and GP characteristics associated with medicine recommendations, e.g. stronger opioids were less likely recommended for Indigenous patients [odds ratio 0.15 (95% CI 0.04-0.56)].
conclusionsGP's analgesic recommendations for spinal pain have become increasingly divergent from guideline recommendations over time.
Indexed as
Identifiers
28639074What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.